Literature DB >> 17998025

The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese.

I-Te Lee1, Wen-Jane Lee, Chien-Ning Huang, Wayne H-H Sheu.   

Abstract

Metabolic syndrome, which involves different pathological mechanisms in associated disorders including inflammation, endothelial dysfunction, and insulin resistance, results in the development of cardiovascular diseases. The effect of the accumulative abnormalities of metabolic components and the relationship of each component to these associated disorders have not been clearly delineated. We therefore conducted a cross-sectional study to investigate the accumulative effect and the correlation of components of the metabolic syndrome to C-reactive protein (CRP), urinary albumin excretion (UAE), and the homeostasis model assessment for insulin resistance index (HOMA-IR). A total of 200 nondiabetic subjects received assessment of metabolic syndrome and measurements of serum CRP, UAE, and HOMA-IR. As the number of abnormalities of metabolic syndrome increased in subjects, the CRP, UAE, and HOMA-IR were significantly elevated (P value for trend less than .001, all). Waist circumference was an independent risk factor for CRP (P = .012); waist circumference and systolic blood pressure were independent risk factors for UAE (P = .010 and P < .001, respectively); and waist circumference, triglyceride, and glucose were independent risk factors for HOMA-IR (P < .001, all). More metabolic abnormalities were associated with higher risk of inflammation, urinary albumin, and insulin resistance. Waist circumference was the only independent risk factor for all 3 associated diseases in metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998025     DOI: 10.1016/j.metabol.2007.07.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

Authors:  Joachim H Ix; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

2.  Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.

Authors:  Erdembileg Anuurad; Russell P Tracy; Thomas A Pearson; Kyoungmi Kim; Lars Berglund
Journal:  Atherosclerosis       Date:  2008-12-06       Impact factor: 5.162

3.  Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.

Authors:  I-Te Lee; Yen-Feng Chiu; Chii-Min Hwu; Chih-Tsueng He; Fu-Tien Chiang; Yu-Chun Lin; Themistocles Assimes; J David Curb; Wayne H-H Sheu
Journal:  Cardiovasc Diabetol       Date:  2012-04-26       Impact factor: 9.951

4.  Blood Mercury and Insulin Resistance in Nondiabetic Koreans (KNHANES 2008-2010).

Authors:  Kyu-Nam Kim; Soo-Jung Park; Beomhee Choi; Nam-Seok Joo
Journal:  Yonsei Med J       Date:  2015-07       Impact factor: 2.759

5.  Association of C-Reactive Protein and Metabolic Disorder in a Chinese Population.

Authors:  Mingxia Sun; Liying Zhang; Shanying Chen; Xinyu Liu; Xiaofei Shao; Hequn Zou
Journal:  Int J Environ Res Public Health       Date:  2015-07-17       Impact factor: 3.390

6.  Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.

Authors:  I-Te Lee; Chia-Po Fu; Wen-Jane Lee; Kae-Woei Liang; Shih-Yi Lin; Chu-Jen Wan; Wayne Huey-Herng Sheu
Journal:  Diabetol Metab Syndr       Date:  2014-02-13       Impact factor: 3.320

7.  Association of Microalbuminuria with Metabolic Syndrome among Aged Population.

Authors:  Xiao-Hong Li; Hai-Yan Lin; Shu-Hua Wang; Li-Ying Guan; Yi-Bing Wang
Journal:  Biomed Res Int       Date:  2016-04-21       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.